Kalkman, Hans O.
University of Zurich · University Hospital Zurich · Psychiatrische Universitätsklinik Zürich
4 papers on CoChat
Most cited papers
- Verified
Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects
Rupprecht, R., Rammes, G., Eser, D., Baghai, T. C., Schüle, C., Nothdurfter, C., Troxler, T., Gentsch, C., Kalkman, H. O., Chaperon, F., et al. (2009) · Science
Pharmacological Receptor Mechanisms and EffectsNeuroscience and Neuropharmacology Research
Cited by 328
- Verified
Antidepressant therapies inhibit inflammation and microglial M1-polarization
Kalkman, H. O., & Feuerbach, D. (2016) · Pharmacology & Therapeutics
Tryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms
Cited by 212
- Verified
A review of the evidence for the canonical Wnt pathway in autism spectrum disorders
Kalkman, H. (2012) · Molecular Autism
Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental Disorders
Cited by 142
- Verified
Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles
Kalkman, H. O. (2023) · Biomedicines
Treatment of Major DepressionTryptophan and brain disorders
Cited by 18
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free